Richard C. Young & CO. LTD. grew its stake in shares of Clorox Co (NYSE:CLX) by 422.3% in the 1st quarter, Holdings Channel reports. The firm owned 6,779 shares of the company’s stock after acquiring an additional 5,481 shares during the quarter. Richard C. Young & CO. LTD.’s holdings in Clorox were worth $1,088,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. JPMorgan Chase & Co. increased its position in Clorox by 5.2% during the third quarter. JPMorgan Chase & Co. now owns 1,019,248 shares of the company’s stock worth $153,305,000 after buying an additional 50,360 shares in the last quarter. Meeder Asset Management Inc. purchased a new position in Clorox during the fourth quarter worth $26,000. BB&T Corp increased its position in Clorox by 2.6% during the fourth quarter. BB&T Corp now owns 6,953 shares of the company’s stock worth $1,072,000 after buying an additional 173 shares in the last quarter. Strs Ohio increased its position in Clorox by 77.2% during the fourth quarter. Strs Ohio now owns 22,442 shares of the company’s stock worth $3,459,000 after buying an additional 9,778 shares in the last quarter. Finally, IFM Investors Pty Ltd increased its position in Clorox by 9.2% during the fourth quarter. IFM Investors Pty Ltd now owns 7,274 shares of the company’s stock worth $1,121,000 after buying an additional 610 shares in the last quarter. 77.92% of the stock is owned by institutional investors and hedge funds.

CLX has been the subject of several recent research reports. Wells Fargo & Co reissued a “hold” rating and set a $157.00 price target on shares of Clorox in a research report on Monday, February 4th. BMO Capital Markets set a $175.00 price objective on Clorox and gave the company a “buy” rating in a research report on Tuesday, February 5th. Citigroup set a $171.00 price objective on Clorox and gave the company a “hold” rating in a research report on Tuesday, February 5th. Barclays reaffirmed a “hold” rating and issued a $142.00 price objective on shares of Clorox in a research report on Wednesday, February 6th. Finally, Credit Suisse Group started coverage on Clorox in a research report on Wednesday, March 6th. They issued an “outperform” rating and a $172.00 price objective for the company. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company. Clorox has a consensus rating of “Hold” and a consensus target price of $149.29.

In related news, SVP Andrew J. Mowery sold 5,340 shares of the business’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $156.44, for a total value of $835,389.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.40% of the stock is owned by insiders.

Clorox stock traded down $1.25 during midday trading on Friday, hitting $149.63. The stock had a trading volume of 728,733 shares, compared to its average volume of 1,042,215. The company has a quick ratio of 0.66, a current ratio of 1.10 and a debt-to-equity ratio of 2.93. The firm has a market cap of $19.06 billion, a P/E ratio of 23.90, a P/E/G ratio of 4.31 and a beta of 0.31. Clorox Co has a 12 month low of $119.78 and a 12 month high of $167.70.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, May 1st. The company reported $1.44 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.47 by ($0.03). The firm had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.57 billion. Clorox had a net margin of 12.68% and a return on equity of 108.82%. The firm’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.37 earnings per share. As a group, equities research analysts anticipate that Clorox Co will post 6.29 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 16th. Investors of record on Wednesday, July 31st will be issued a $1.06 dividend. This is a positive change from Clorox’s previous quarterly dividend of $0.96. This represents a $4.24 annualized dividend and a yield of 2.83%. The ex-dividend date is Tuesday, July 30th. Clorox’s payout ratio is currently 61.34%.

ILLEGAL ACTIVITY WARNING: “Richard C. Young & CO. LTD. Buys 5,481 Shares of Clorox Co (CLX)” was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this article on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The legal version of this article can be read at https://www.dailypolitical.com/2019/05/25/richard-c-young-co-ltd-buys-5481-shares-of-clorox-co-clx.html.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Article: Index Funds

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.